[DOI] [PMC free article] [PubMed] [Google Scholar] 127.Adams J.B., Audhya T., Geis E., Gehn E., Fimbres V., Pollard E.L., Mitchell J., Ingram J., Hellmers R., Laake D., et al
Recent studies and regulatory reviews have examined whether Ozempic and other GLP-1 receptor agonist drugs may carry a significantly increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare optic nerve condition that can cause sudden vision loss and permanent visual impairment
These include insomnia or sedation, activation or increased anxiety, and gastrointestinal symptoms such as nausea or diarrhea
A 12-year survey between 2005 and 2016 including more than 15,000 women in the US revealed that more than half of the respondents had experienced a form of incontinence